NCT04974866View on ClinicalTrials.gov

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2026

Conditions

Carcinoma, Adenoid Cystic

Interventions

DRUG

EGFR-TK Inhibitor

epidermal growth factor receptor tyrosine kinase inhibitors

Trial Locations (1)

266042

RECRUITING

Qingdao central Hospital, Qingdao

All Listed Sponsors

lead

Qingdao Central Hospital

OTHER